top of page

News& Press Releases
Search


Anders Nordström. New Chairman of the Board
Join us in welcoming Anders Nordström to the Offspring Biosciences family as the new Chairman of the Board. With a rich background in the Life Science industry, Anders has served and serves as Chairman or Board member for prominent companies such as Pelago Bioscience, Vanadis Diagnostics, Cartana, Halo Genomics, Moleculent, , Genagon Therapeutics, Fenomark Diagnostics and Epigenica. His expertise extends to pivotal roles, including as Senior Advisor for Business Developme
frankhammar
Jan 22, 20241 min read


Offspring Biosciences in research collaboration with BioArctic
We are proud to have the opportunity to work in collaboration together with BioArctic in this study we have been performing IHC binding of Lecanemab in Down syndrome and Alzheimer's disease This study shows for or the first time, Lecanemab (an antibody with higher avidity for toxic Aβ aggregates), binding to Aβ protofibrils and plaques in people with Down syndrome is demonstrated Lecanemab currently in phase 3 clinical studies and has shown to reduce brain amyloid levels in t
-
Sep 16, 20211 min read


Offspring Biosciences in research collaboration developing alpha-synuclein PET ligand
New publication, “Identification and in vitro characterization of C05-01, a PBB3 derivative with improved affinity for alpha-synuclein” together with Karolinska Institutet, Andrea Varrone research group. The approach used in this study also shows that TMAs are a useful tool for the evaluation of ligands in tissue from different proteinopathies, using both fluorescence and autoradiographic assays https://doi.org/10.1016/j.brainres.2020.147131 The neuropathological hallmark o
-
Sep 16, 20211 min read
bottom of page
